President & Immunovant CEO
Tue, Oct 7, 2025
Oct 7
107,131 shares @ $7.45
Increased holdings by +6.80%
86th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
39% win rate · -1.6% median edge vs SPY (69 trades, 90-day)
Insider trade was 54% below market price
Price 40% above 200-day moving average